BeiGene Revenue

BeiGene had revenue of 7.35B CNY in the quarter ending September 30, 2024, with 39.54% growth. This brings the company's revenue in the last twelve months to 23.51B, up 50.22% year-over-year. In the year 2023, BeiGene had annual revenue of 2.46B with 73.65% growth.

Revenue (ttm)

23.51B CNY

Revenue Growth

+50.22%

P/S Ratio

n/a

Revenue / Employee

2.22M CNY

Employees

10,600

Market Cap

18.75B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.46B	1.04B	73.65%
Dec 31, 2022	1.42B	239.64M	20.37%
Dec 31, 2021	1.18B	867.41M	280.83%
Dec 31, 2020	308.87M	-119.34M	-27.87%
Dec 31, 2019	428.21M	229.99M	116.03%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sandoz Group AG	10.11B
Telix Pharmaceuticals Limited	430.80M
Elekta AB (publ)	1.66B
Ryman Healthcare Limited	458.44M
Verano Holdings Corp.	897.57M
Vireo Growth Inc.	98.53M
Medexus Pharmaceuticals Inc.	104.76M

Revenue Rankings